Apex Trader Funding - Halma Buys Rovers Medical Devices For 92 1 Mln 8ab765f0

Home
About
Tools
FAQ
Products
Help Desk
Testimonials

Login

Apex Trader Funding - News

Halma Buys Rovers Medical Devices for $92.1 Mln

Halma Buys Rovers Medical Devices for $92.1 Mln

Apex Trader Funding Inc.
2028 E. Ben White Blvd Ste 240 -9873
Austin, TX 78741
1-855-273-9873 (CST, M-F 9am to 5pm)
Contact Support 24/7 via help desk

Policies

Privacy & Policy
Terms & Conditions
Accepted Countries

Resources

Affiliates
Coupon Code
Payouts

Useful Links

News
Bounty Program
Logos

Our Partners

partner image

RISK DISCLOSURE:

This is not an investment opportunity. You do not deposit any funds for investment. We do not ask for any funds for investment. At no time do you risk your own capital. There are no promises of rewards or returns.

HYPOTHETICAL PERFORMANCE DISCLOSURE:

Hypothetical performance results have many inherent limitations, some of which are described below. No representation is being made that any account will or is likely to achieve profits or losses similar to those shown. In fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. For example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses is material points, which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program, which cannot be fully accounted for in the preparation of hypothetical performance results and all of which can adversely affect trading results. Testimonials appearing on this website may not be representative of other clients or customers and are not a guarantee of future performance or success.

AVAILABLE INSTRUMENTS:

Apex Trader Funding customers are allowed to only trade Futures products, listed on the following exchanges: CME, COMEX, NYMEX & CBOT. Trading of Spot Currencies, CFD's Stocks, Options, and Cryptocurrencies are not permitted or available in our programs vendors or platforms.

EVALUATION DISCLAIMER:

The customer pass rate of the evaluation program was 43.13% between January 1, 2023 – Sept 1, 2023, who traded at least one evaluation and obtained a PA Account during this time period. The Evaluation and PA are meant to be as close to a realistic simulation of trading under actual market conditions, including commissions, to mimic real market conditions, and the evaluation is difficult to pass even for experienced traders. The event is not meant to train the customer to be better but to be a challenge to pass. The Evaluation is not suggested for individuals with little to no trading experience.

CUSTOMER COMPENSATION DISCLOSURE:

All trades presented for compensation to customers should be considered hypothetical and should not be expected to be replicated in a live trading account. PA Accounts may represent simulated accounts or live or copied accounts. Testimonials and payouts appearing on this website may not be representative of other clients or customers and are not a guarantee of future performance or success.

© 2021-2031, Apex Trader Funding Inc. All rights reserved.